Microfluidic-based direct identification of virus-neutralizing antibodies from comprehensive B-cell repertoires of elite controllers of infection (##DIVA#) for a rapid anti-pandemic response

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

46963.1 IP-LS

Project title

Microfluidic-based direct identification of virus-neutralizing antibodies from comprehensive B-cell repertoires of elite controllers of infection (##DIVA#) for a rapid anti-pandemic response

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Inserted texts

Category	Text
Short description (German)	Microfluidic-based direct identification of virus-neutralizing antibodies from comprehensive B-cell repertoires of elite controllers of infection (##DIVA#) for a rapid anti-pandemic response
Short description (English)	Microfluidic-based direct identification of virus-neutralizing antibodies from comprehensive B-cell repertoires of elite controllers of infection (##DIVA#) for a rapid anti-pandemic response
Abstract (German)	The innovative microfluidic screening platform #DIVA will allow direct discovery of neutralizing antibodies against viral infections and thus shorten the drug development process. It will be benchmarked with the current pandemic SARS-CoV-2 and applied to the discovery of CMV-neutralizing antibodies.